| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | olfactory receptor activity | OR10J3 OR2W1 OR14I1 OR2B6 OR2K2 OR51E1 OR4S1 OR13D1 OR14A2 OR6C70 OR2T27 OR4C16 OR52J3 OR52E2 OR1F1 OR52A4P | 1.10e-05 | 431 | 206 | 16 | GO:0004984 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR10J3 OR2W1 OR14I1 OR2B6 GLP2R OR2K2 OR51E1 OR4S1 OR13D1 OR14A2 OR6C70 TAS2R20 GPR12 HTR1D HTR2B OR2T27 OR4C16 NTSR1 GPR183 ADGRA2 OR52J3 OR52E2 OR1F1 OR52A4P | 1.52e-05 | 884 | 206 | 24 | GO:0004930 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA2 ATP8B4 ATP7A ATRX CFTR BLM MDN1 STARD9 ATP2C2 ABCD4 RFT1 DNAH5 DNHD1 KIF13B ZNFX1 HELQ DHX30 ABCA6 MACF1 | 2.14e-05 | 614 | 206 | 19 | GO:0140657 |
| GeneOntologyMolecularFunction | transporter activity | TRPM6 SLC46A2 ABCA2 CNNM2 ATP8B4 ATP7A CFTR TRPM2 SLC35E2B SLC39A8 CHRND CHRNE CHRNG CIDEA NALCN SLC35E2A ATP2C2 ABCD4 KCNMA1 RFT1 CACNA1C NIPAL4 SLC26A3 SLC7A6 CNNM4 ABCA6 LRP2 SLC35F2 SEC63 SLC2A12 | 2.43e-05 | 1289 | 206 | 30 | GO:0005215 |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 3.71e-05 | 37 | 206 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 4.24e-05 | 38 | 206 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA2 ATP8B4 ATP7A ATRX CFTR BLM MDN1 ATP2C2 ABCD4 DNAH5 KIF13B HELQ DHX30 ABCA6 MACF1 | 5.68e-05 | 441 | 206 | 15 | GO:0016887 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR10J3 OR2W1 OR14I1 OR2B6 CHRND CHRNE CHRNG GLP2R OR2K2 OR51E1 OR4S1 OR13D1 OR14A2 OR6C70 TAS2R20 GPR12 HTR1D HTR2B OR2T27 OR4C16 NTSR1 GPR183 ADGRA2 LEPR OR52J3 OR52E2 OR1F1 TLR10 OR52A4P TLR2 | 5.94e-05 | 1353 | 206 | 30 | GO:0004888 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.68e-04 | 11 | 206 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | histone kinase activity | 1.86e-04 | 28 | 206 | 4 | GO:0035173 | |
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | 2.05e-04 | 82 | 206 | 6 | GO:1990756 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | TRPM6 SLC46A2 ABCA2 CNNM2 ATP7A CFTR TRPM2 SLC35E2B SLC39A8 CHRND CHRNE CHRNG NALCN SLC35E2A ATP2C2 ABCD4 KCNMA1 CACNA1C NIPAL4 SLC26A3 SLC7A6 CNNM4 ABCA6 SLC35F2 SEC63 SLC2A12 | 2.13e-04 | 1180 | 206 | 26 | GO:0022857 |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 2.55e-04 | 55 | 206 | 5 | GO:0042974 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 3.62e-04 | 14 | 206 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | 4.54e-04 | 95 | 206 | 6 | GO:0140767 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 6.61e-04 | 17 | 206 | 3 | GO:0022848 | |
| GeneOntologyMolecularFunction | magnesium ion transmembrane transporter activity | 7.88e-04 | 18 | 206 | 3 | GO:0015095 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 9.40e-04 | 109 | 206 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | transition metal ion transmembrane transporter activity | 1.08e-03 | 44 | 206 | 4 | GO:0046915 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.25e-03 | 21 | 206 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.28e-03 | 46 | 206 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC46A2 ABCA2 ATP7A CFTR SLC35E2B SLC39A8 SLC35E2A ATP2C2 ABCD4 SLC26A3 SLC7A6 ABCA6 SLC2A12 | 1.42e-03 | 477 | 206 | 13 | GO:0022804 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.62e-03 | 49 | 206 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 1.65e-03 | 23 | 206 | 3 | GO:0015464 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR10J3 OR2W1 OR14I1 OR2B6 OR2K2 OR51E1 OR4S1 OR13D1 OR14A2 OR6C70 TAS2R20 OR2T27 OR4C16 OR52J3 OR52E2 OR1F1 OR52A4P TLR2 | 7.02e-06 | 524 | 209 | 18 | GO:0009593 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR10J3 OR2W1 OR14I1 OR2B6 OR2K2 OR51E1 OR4S1 OR13D1 OR14A2 OR6C70 OR2T27 OR4C16 OR52J3 OR52E2 OR1F1 OR52A4P | 9.14e-06 | 432 | 209 | 16 | GO:0050911 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR10J3 OR2W1 OR14I1 OR2B6 OR2K2 OR51E1 OR4S1 OR13D1 OR14A2 OR6C70 TAS2R20 OR2T27 OR4C16 OR52J3 OR52E2 OR1F1 OR52A4P | 9.80e-06 | 485 | 209 | 17 | GO:0050907 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR10J3 OR2W1 OR14I1 OR2B6 OR2K2 OR51E1 OR4S1 OR13D1 OR14A2 OR6C70 OR2T27 OR4C16 OR52J3 OR52E2 OR1F1 OR52A4P | 2.26e-05 | 465 | 209 | 16 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR10J3 OR2W1 OR14I1 OR2B6 OR2K2 OR51E1 OR4S1 OR13D1 OR14A2 OR6C70 TAS2R20 OR2T27 OR4C16 NTSR1 OR52J3 OR52E2 OR1F1 OR52A4P | 2.86e-05 | 582 | 209 | 18 | GO:0050906 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR10J3 OR2W1 OR14I1 OR2B6 OR2K2 OR51E1 OR4S1 OR13D1 OR14A2 OR6C70 TAS2R20 OR2T27 OR4C16 OR52J3 OR52E2 OR1F1 OR52A4P | 4.51e-05 | 547 | 209 | 17 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR10J3 DACH1 OR2W1 OR14I1 OR2B6 OR2K2 OR51E1 OR4S1 OR13D1 OR14A2 OR6C70 TAS2R20 OR2T27 OR4C16 NTSR1 OR52J3 OR52E2 OR1F1 OR52A4P TLR2 | 4.84e-05 | 722 | 209 | 20 | GO:0051606 |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | ABCA2 CFTR HMGCR KCNMA1 PLA2G6 PLEC CACNA1C HTR1D HTR2B LEPR ACE2 LRP2 PDE5A | 5.23e-05 | 344 | 209 | 13 | GO:0003018 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR10J3 LRRK2 OR2W1 OR14I1 OR2B6 GLP2R GPR180 OR2K2 OR51E1 NLN OR4S1 OR13D1 OR14A2 OR6C70 TAS2R20 VIP GPR12 AKAP5 HTR1D HTR2B OR2T27 OR4C16 NTSR1 GPR183 ADGRA2 OR52J3 OR52E2 OR1F1 OR52A4P PDE5A | 7.56e-05 | 1395 | 209 | 30 | GO:0007186 |
| GeneOntologyBiologicalProcess | intestine smooth muscle contraction | 1.17e-04 | 10 | 209 | 3 | GO:0014827 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | CYP1B1 CATSPERE ATRX CFTR LRRK2 DACH1 NDRG3 PTPRN GARIN1B TDRD6 HERC2 PRAMEF11 PAQR7 DNHD1 HNF1B SLC26A3 CIP2A PRAMEF15 PRAMEF4 MEI1 DACH2 MROH2B H1-6 LRP2 PDE5A RAI14 PRKDC | 1.37e-04 | 1235 | 209 | 27 | GO:0003006 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | ATP7A CFTR LRRK2 HMGCR KCNMA1 PLA2G6 CACNA1C HNF1B HTR1D HTR2B CARMIL1 E2F4 ACE2 TLR2 MACF1 PDE5A NCKAP1L | 1.97e-04 | 618 | 209 | 17 | GO:0090066 |
| GeneOntologyBiologicalProcess | manganese ion transmembrane transport | 2.11e-04 | 12 | 209 | 3 | GO:0071421 | |
| GeneOntologyBiologicalProcess | urinary bladder smooth muscle contraction | 2.11e-04 | 12 | 209 | 3 | GO:0014832 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process | SLC46A2 PRAMEF25 ATP7A PRAMEF9 CFTR LRRK2 HMGCR CIDEA BLM PRAMEF11 IL19 VIP HNF1B HTR2B PRAMEF15 NTSR1 PRAMEF4 BBS10 MST1 TRIM32 LRP2 MST1L PRKDC PRAMEF27 NCKAP1L | 2.14e-04 | 1133 | 209 | 25 | GO:0043066 |
| GeneOntologyBiologicalProcess | regulation of tube diameter | 2.27e-04 | 202 | 209 | 9 | GO:0035296 | |
| GeneOntologyBiologicalProcess | blood vessel diameter maintenance | 2.27e-04 | 202 | 209 | 9 | GO:0097746 | |
| GeneOntologyBiologicalProcess | sensory perception | OR10J3 OR2W1 OR14I1 OR2B6 OR2K2 OR51E1 OR4S1 OR13D1 OR14A2 OR6C70 KCNMA1 TAS2R20 OR2T27 OR4C16 NTSR1 PKHD1L1 BBS10 OR52J3 OR52E2 OR1F1 CNNM4 OR52A4P HMCN1 LRP2 | 2.33e-04 | 1072 | 209 | 24 | GO:0007600 |
| GeneOntologyBiologicalProcess | regulation of tube size | 2.35e-04 | 203 | 209 | 9 | GO:0035150 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 2.36e-04 | 121 | 209 | 7 | GO:0051899 | |
| GeneOntologyBiologicalProcess | DNA integration | 2.72e-04 | 13 | 209 | 3 | GO:0015074 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 1.04e-04 | 47 | 209 | 5 | GO:0031462 | |
| Domain | ARM-type_fold | MON2 DCAF1 CAND1 LRRK2 UNC45A DNAAF5 NCAPG NF1 AP2B1 ARMH3 CIP2A UBR4 ZNFX1 HUWE1 MEI1 AP4E1 MROH2B INTS4 PRKDC STAG2 | 8.59e-10 | 339 | 202 | 20 | IPR016024 |
| Domain | ARM-like | MON2 DCAF1 CAND1 LRRK2 UNC45A DNAAF5 NCAPG NF1 AP2B1 CIP2A HUWE1 MEI1 AP4E1 MROH2B INTS4 PRKDC STAG2 | 6.37e-09 | 270 | 202 | 17 | IPR011989 |
| Domain | - | MON2 DCAF1 CAND1 LRRK2 UNC45A DNAAF5 NCAPG NF1 AP2B1 CIP2A AP4E1 MROH2B INTS4 PRKDC | 1.42e-07 | 222 | 202 | 14 | 1.25.10.10 |
| Domain | Olfact_rcpt | OR10J3 OR2W1 OR14I1 OR2B6 OR2K2 OR51E1 OR4S1 OR13D1 OR6C70 OR2T27 OR4C16 OR52J3 OR52E2 OR1F1 OR52A4P | 2.58e-05 | 393 | 202 | 15 | IPR000725 |
| Domain | GPCR_Rhodpsn_7TM | OR10J3 OR2W1 OR14I1 OR2B6 OR2K2 OR51E1 OR4S1 OR13D1 OR6C70 GPR12 HTR1D HTR2B OR2T27 OR4C16 NTSR1 GPR183 OR52J3 OR52E2 OR1F1 OR52A4P | 4.15e-05 | 670 | 202 | 20 | IPR017452 |
| Domain | PRAME_family | 4.53e-05 | 19 | 202 | 4 | IPR026271 | |
| Domain | 7tm_1 | OR10J3 OR2W1 OR14I1 OR2B6 OR2K2 OR51E1 OR4S1 OR13D1 OR6C70 GPR12 HTR1D HTR2B OR2T27 OR4C16 NTSR1 GPR183 OR52J3 OR52E2 OR1F1 OR52A4P | 4.79e-05 | 677 | 202 | 20 | PF00001 |
| Domain | - | PRAMEF25 LRRK2 CEP78 TBCE CARMIL1 PRAMEF15 PRAMEF4 ADGRA2 TLR10 LRRN3 TLR2 PRAMEF27 LRRC17 | 4.94e-05 | 321 | 202 | 13 | 3.80.10.10 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR10J3 OR2W1 OR14I1 OR2B6 OR2K2 OR51E1 OR4S1 OR13D1 OR6C70 GPR12 HTR1D HTR2B OR2T27 OR4C16 NTSR1 GPR183 OR52J3 OR52E2 OR1F1 OR52A4P | 5.64e-05 | 685 | 202 | 20 | PS00237 |
| Domain | L_dom-like | PRAMEF25 LRRK2 CEP78 TBCE CARMIL1 PRAMEF15 PRAMEF4 ADGRA2 TLR10 LRRN3 TLR2 PRAMEF27 LRRC17 | 6.16e-05 | 328 | 202 | 13 | IPR032675 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR10J3 OR2W1 OR14I1 OR2B6 OR2K2 OR51E1 OR4S1 OR13D1 OR6C70 GPR12 HTR1D HTR2B OR2T27 OR4C16 NTSR1 GPR183 OR52J3 OR52E2 OR1F1 OR52A4P | 6.36e-05 | 691 | 202 | 20 | PS50262 |
| Domain | GPCR_Rhodpsn | OR10J3 OR2W1 OR14I1 OR2B6 OR2K2 OR51E1 OR4S1 OR13D1 OR6C70 GPR12 HTR1D HTR2B OR2T27 OR4C16 NTSR1 GPR183 OR52J3 OR52E2 OR1F1 OR52A4P | 6.49e-05 | 692 | 202 | 20 | IPR000276 |
| Domain | HEAT_REPEAT | 1.10e-04 | 70 | 202 | 6 | PS50077 | |
| Domain | HEAT | 1.65e-04 | 48 | 202 | 5 | PF02985 | |
| Domain | TECPR | 3.47e-04 | 3 | 202 | 2 | SM00706 | |
| Domain | VPS13 | 3.47e-04 | 3 | 202 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 3.47e-04 | 3 | 202 | 2 | PF16910 | |
| Domain | VPS13 | 3.47e-04 | 3 | 202 | 2 | PF16908 | |
| Domain | - | 3.47e-04 | 3 | 202 | 2 | 4.10.1130.10 | |
| Domain | VPS13_N2 | 3.47e-04 | 3 | 202 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 3.47e-04 | 3 | 202 | 2 | IPR031642 | |
| Domain | Beta-propeller_rpt_TECPR | 3.47e-04 | 3 | 202 | 2 | IPR006624 | |
| Domain | HEAT | 4.05e-04 | 58 | 202 | 5 | IPR000357 | |
| Domain | RasGAP | 4.16e-04 | 14 | 202 | 3 | SM00323 | |
| Domain | RasGAP_CS | 4.16e-04 | 14 | 202 | 3 | IPR023152 | |
| Domain | RasGAP | 5.15e-04 | 15 | 202 | 3 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 5.15e-04 | 15 | 202 | 3 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 5.15e-04 | 15 | 202 | 3 | PS50018 | |
| Domain | Nicotinic_acetylcholine_rcpt | 6.29e-04 | 16 | 202 | 3 | IPR002394 | |
| Domain | DUF21 | 6.88e-04 | 4 | 202 | 2 | IPR002550 | |
| Domain | SHR-BD | 6.88e-04 | 4 | 202 | 2 | IPR009543 | |
| Domain | G8_domain | 6.88e-04 | 4 | 202 | 2 | IPR019316 | |
| Domain | G8 | 6.88e-04 | 4 | 202 | 2 | PS51484 | |
| Domain | G8 | 6.88e-04 | 4 | 202 | 2 | SM01225 | |
| Domain | G8 | 6.88e-04 | 4 | 202 | 2 | PF10162 | |
| Domain | VPS13_C | 6.88e-04 | 4 | 202 | 2 | PF16909 | |
| Domain | VPS13_C | 6.88e-04 | 4 | 202 | 2 | IPR031645 | |
| Domain | DUF21 | 6.88e-04 | 4 | 202 | 2 | PF01595 | |
| Domain | SHR-BD | 6.88e-04 | 4 | 202 | 2 | PF06650 | |
| Domain | Kringle_CS | 7.58e-04 | 17 | 202 | 3 | IPR018056 | |
| Domain | KRINGLE_1 | 7.58e-04 | 17 | 202 | 3 | PS00021 | |
| Domain | KR | 7.58e-04 | 17 | 202 | 3 | SM00130 | |
| Domain | Kringle | 7.58e-04 | 17 | 202 | 3 | IPR000001 | |
| Domain | KRINGLE_2 | 7.58e-04 | 17 | 202 | 3 | PS50070 | |
| Domain | Kringle | 7.58e-04 | 17 | 202 | 3 | PF00051 | |
| Domain | RasGAP_dom | 9.02e-04 | 18 | 202 | 3 | IPR001936 | |
| Domain | Toll-like_receptor | 1.14e-03 | 5 | 202 | 2 | IPR017241 | |
| Domain | Autophagy-rel_C | 1.14e-03 | 5 | 202 | 2 | IPR015412 | |
| Domain | PAN_AP | 1.14e-03 | 5 | 202 | 2 | SM00473 | |
| Domain | ATG_C | 1.14e-03 | 5 | 202 | 2 | PF09333 | |
| Domain | - | 1.70e-03 | 6 | 202 | 2 | 3.90.1290.10 | |
| Domain | ABC_tran | 1.78e-03 | 48 | 202 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.78e-03 | 48 | 202 | 4 | PS50893 | |
| Domain | - | 1.88e-03 | 23 | 202 | 3 | 1.20.120.370 | |
| Domain | Acetylcholine_rcpt_TM | 1.88e-03 | 23 | 202 | 3 | IPR027361 | |
| Domain | RCC1/BLIP-II | 1.88e-03 | 23 | 202 | 3 | IPR009091 | |
| Domain | ABC_TRANSPORTER_1 | 1.92e-03 | 49 | 202 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 2.07e-03 | 50 | 202 | 4 | IPR003439 | |
| Domain | P-loop_NTPase | ABCA2 ATRX CFTR LRRK2 BLM SAMD9L NWD2 MDN1 STARD9 ABCD4 DNAH5 DNHD1 KIF13B ZNFX1 HELQ DHX30 ABCA6 PALS2 HYDIN | 2.19e-03 | 848 | 202 | 19 | IPR027417 |
| Domain | Pan_app | 2.36e-03 | 7 | 202 | 2 | IPR003609 | |
| Domain | Plectin | 2.36e-03 | 7 | 202 | 2 | PF00681 | |
| Domain | Plectin_repeat | 2.36e-03 | 7 | 202 | 2 | IPR001101 | |
| Domain | PAN | 2.36e-03 | 7 | 202 | 2 | PS50948 | |
| Domain | Ski_Sno | 2.36e-03 | 7 | 202 | 2 | PF02437 | |
| Domain | - | 2.36e-03 | 7 | 202 | 2 | 3.10.260.20 | |
| Domain | Transform_Ski | 2.36e-03 | 7 | 202 | 2 | IPR003380 | |
| Domain | PAN_1 | 2.36e-03 | 7 | 202 | 2 | PF00024 | |
| Domain | PLEC | 2.36e-03 | 7 | 202 | 2 | SM00250 | |
| Domain | Leu-rich_rpt | 2.83e-03 | 271 | 202 | 9 | IPR001611 | |
| Domain | Cys-rich_flank_reg_C | 2.94e-03 | 90 | 202 | 5 | IPR000483 | |
| Domain | LRRCT | 2.94e-03 | 90 | 202 | 5 | SM00082 | |
| Domain | HECT | 3.01e-03 | 27 | 202 | 3 | PF00632 | |
| Domain | HECTc | 3.01e-03 | 27 | 202 | 3 | SM00119 | |
| Domain | HECT_dom | 3.01e-03 | 27 | 202 | 3 | IPR000569 | |
| Domain | HECT | 3.01e-03 | 27 | 202 | 3 | PS50237 | |
| Domain | Chorein_N | 3.12e-03 | 8 | 202 | 2 | PF12624 | |
| Domain | Pectin_lyase_fold/virulence | 3.12e-03 | 8 | 202 | 2 | IPR011050 | |
| Domain | VPS13_N | 3.12e-03 | 8 | 202 | 2 | IPR026854 | |
| Domain | Coatomer/calthrin_app_sub_C | 3.12e-03 | 8 | 202 | 2 | IPR009028 | |
| Domain | - | ABCA2 ATRX CFTR LRRK2 BLM SAMD9L NWD2 MDN1 ABCD4 DNAH5 DNHD1 ZNFX1 HELQ DHX30 ABCA6 PALS2 HYDIN | 3.13e-03 | 746 | 202 | 17 | 3.40.50.300 |
| Pathway | REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS | 4.17e-05 | 7 | 152 | 3 | M27596 | |
| Pathway | REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS | 4.17e-05 | 7 | 152 | 3 | MM15311 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR10J3 OR2W1 OR14I1 OR2B6 OR2K2 OR51E1 OR4S1 OR13D1 OR14A2 OR6C70 OR2T27 OR4C16 OR52J3 OR52E2 OR1F1 | 4.48e-05 | 417 | 152 | 15 | M4072 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR10J3 OR2W1 OR14I1 OR2B6 OR2K2 OR51E1 OR4S1 OR13D1 OR6C70 OR2T27 OR4C16 OR52J3 OR52E2 OR1F1 | 8.08e-05 | 389 | 152 | 14 | M14091 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR10J3 OR2W1 OR14I1 OR2B6 OR2K2 OR51E1 OR4S1 OR13D1 OR14A2 OR6C70 KCNMA1 TAS2R20 OR2T27 OR4C16 OR52J3 OR52E2 OR1F1 LRP2 | 1.70e-04 | 636 | 152 | 18 | M41834 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | CYP1B1 ZBTB20 HMGCR CEMIP2 BLM NLN NF1 MDN1 VPS13A UNC93B1 RFT1 HERC1 GPAT4 CAVIN2 TBCE PIGS DOLK TMED7 HUWE1 SLC7A6 TRIM7 FANCI INTS4 MACF1 PRKDC | 8.30e-09 | 1061 | 211 | 25 | 33845483 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 ABCA2 OBSCN SLC35E2B ACOX3 MDN1 PLA2G6 PLEC HERC2 HERC1 GPAT4 UBR4 NTSR1 HECTD4 HUWE1 ADGRA2 BTN3A2 TRIM7 DHX30 CCNE1 GAREM2 CDK13 FANCI PRKDC HAS3 | 1.84e-08 | 1105 | 211 | 25 | 35748872 |
| Pubmed | Functional genomic landscape of cancer-intrinsic evasion of killing by T cells. | MON2 ATP7A NDRG3 CHRND DNAAF5 VPS13A RFT1 ARMH3 DOLK SLC7A6 THOC2 OR52J3 AP4E1 TRIM32 PRKDC STAG2 | 2.42e-08 | 457 | 211 | 16 | 32968282 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | MON2 DCAF1 ATRX BLM DNAAF5 FANCB NF1 AP2B1 PLEC RFT1 TBCE KIF13B MBOAT7 CIP2A PIGS CARMIL1 VPS50 E2F4 DHX30 CNNM4 SEPSECS TRIM32 PDE5A RAI14 BBS12 CNOT1 PCK2 | 3.86e-08 | 1321 | 211 | 27 | 27173435 |
| Pubmed | TRPM6 ATRX OBSCN ZBTB40 PLEC HERC1 PRAMEF11 KIF13B PRAMEF15 TMED7 GPR183 PRAMEF4 HUWE1 THOC2 SEPSECS LRP2 MACF1 SLC35F2 SEC63 GEN1 CNOT1 STAG2 LRRC17 NCKAP1L | 5.42e-08 | 1084 | 211 | 24 | 11544199 | |
| Pubmed | MON2 CAND1 HDX UNC45A RRBP1 DNAAF5 NF1 VPS13A HERC2 CIP2A PIGS UBR4 HUWE1 SLC7A6 FANCI PRKDC SEC63 CNOT1 | 1.29e-07 | 657 | 211 | 18 | 36180527 | |
| Pubmed | 2.20e-07 | 3 | 211 | 3 | 34140503 | ||
| Pubmed | 2.20e-07 | 3 | 211 | 3 | 12012784 | ||
| Pubmed | CAND1 UNC45A DNAAF5 NCAPG MDN1 AP2B1 PLEC CIP2A UBR4 HUWE1 THOC2 DHX30 UBE2O FANCI PRKDC CNOT1 STAG2 | 4.30e-07 | 638 | 211 | 17 | 33239621 | |
| Pubmed | NOL6 BLM NF1 MDN1 AP2B1 PLEC HERC2 UBR4 HUWE1 THOC2 DHX30 UBE2O FANCI MACF1 PRKDC CNOT1 STAG2 | 5.92e-07 | 653 | 211 | 17 | 22586326 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRPM6 ATP8B4 CAND1 ATRX VPS13C NOL6 UNC45A RRBP1 UBE4A NCAPG NF1 MDN1 STARD9 TDRD6 DNAH5 DNHD1 UBR4 HUWE1 THOC2 DHX30 UBE2O FANCI PRKDC SEC63 CNOT1 STAG2 | 6.20e-07 | 1425 | 211 | 26 | 30948266 |
| Pubmed | 6.27e-07 | 12 | 211 | 4 | 14557543 | ||
| Pubmed | Primate-specific BTN3A2 protects against SARS-CoV-2 infection by interacting with and reducing ACE2. | 8.77e-07 | 4 | 211 | 3 | 39142074 | |
| Pubmed | Developmental changes in the nicotinic acetylcholine receptor in mouse tongue striated muscle. | 8.77e-07 | 4 | 211 | 3 | 11926244 | |
| Pubmed | Confirmation of quantitative trait loci for ethanol sensitivity in long-sleep and short-sleep mice. | 8.77e-07 | 4 | 211 | 3 | 9049627 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR10J3 OR2W1 OR2B6 OR2K2 OR51E1 OR13D1 OR14A2 OR6C70 OR4C16 OR52J3 OR52E2 OR1F1 | 1.31e-06 | 340 | 211 | 12 | 11875048 |
| Pubmed | OR10J3 OR2W1 OR2B6 OR2K2 OR51E1 OR13D1 OR14A2 OR6C70 OR4C16 OR52J3 OR52E2 OR1F1 | 1.31e-06 | 340 | 211 | 12 | 11802173 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | CAND1 UNC45A GPR180 DNAAF5 NCAPG CEP78 RFT1 MBOAT7 CIP2A PIGS UBR4 HUWE1 CNNM4 UBE2O TRIM32 FANCI PRKDC SEC63 STAG2 PCK2 | 1.41e-06 | 942 | 211 | 20 | 31073040 |
| Pubmed | OR10J3 OR2W1 OR2B6 OR2K2 OR51E1 OR13D1 OR14A2 OR6C70 OR4C16 OR52J3 OR52E2 OR1F1 | 1.43e-06 | 343 | 211 | 12 | 32295537 | |
| Pubmed | OR10J3 OR2W1 OR2B6 OR2K2 OR51E1 OR13D1 OR14A2 OR6C70 OR4C16 OR52J3 OR52E2 OR1F1 | 1.57e-06 | 346 | 211 | 12 | 14611657 | |
| Pubmed | 1.87e-06 | 234 | 211 | 10 | 36243803 | ||
| Pubmed | Properties of embryonic and adult muscle acetylcholine receptors transiently expressed in COS cells. | 2.18e-06 | 5 | 211 | 3 | 2383398 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 2.18e-06 | 5 | 211 | 3 | 12629516 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | OBSCN RRBP1 BLM MDN1 HERC1 ARMH3 CACNA1C HTR2B CARMIL1 VPS50 MEI1 RAI14 CNOT1 HYDIN | 2.44e-06 | 497 | 211 | 14 | 36774506 |
| Pubmed | MON2 CYP1B1 CAND1 NOL6 HMGCR UNC45A DNAAF5 UBE4A NCAPG MDN1 AP2B1 UNC93B1 CIP2A PIGS UBR4 HUWE1 THOC2 CCNE1 CNNM4 FANCI PRKDC SEC63 CNOT1 STAG2 PCK2 | 2.51e-06 | 1440 | 211 | 25 | 30833792 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | MON2 UBE4A MDN1 PLEC PRAMEF11 PRAMEF15 HECTD4 TMED7 PRAMEF4 LEPR FANCI STAG2 | 2.57e-06 | 363 | 211 | 12 | 14691545 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DCAF1 CAND1 NOL6 UNC45A RRBP1 MIDEAS BLM NCAPG NF1 MDN1 AP2B1 MACROH2A2 PLEC HERC2 MBOAT7 UBR4 HUWE1 DHX30 TRIM32 FANCI MACF1 RAI14 PRKDC PCK2 | 2.82e-06 | 1353 | 211 | 24 | 29467282 |
| Pubmed | ABCA2 CAND1 ATP7A ACOX3 BTN3A3 NCAPG NF1 MDN1 AP2B1 HERC2 GPAT4 MBOAT7 PIGS UBR4 VPS50 HUWE1 BTN3A2 FANCI PRKDC CNOT1 STAG2 NCKAP1L | 2.91e-06 | 1168 | 211 | 22 | 19946888 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | CAND1 ATRX UNC45A BLM NCAPG NF1 MDN1 PLEC HUWE1 FANCI MACF1 PRKDC DEPDC7 CNOT1 STAG2 | 3.14e-06 | 582 | 211 | 15 | 20467437 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 4.40e-06 | 202 | 211 | 9 | 33005030 | |
| Pubmed | 4.46e-06 | 152 | 211 | 8 | 34299191 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TBC1D19 CAND1 ZBTB20 ATRX VPS13C TRPM2 OBSCN RRBP1 DNAAF5 TECPR2 KCNMA1 PLA2G6 MACROH2A2 CACNA1C CARMIL1 HECTD4 HUWE1 CNNM4 CDK13 MACF1 SLC35F2 RAI14 PALS2 CNOT1 STAG2 | 4.51e-06 | 1489 | 211 | 25 | 28611215 |
| Pubmed | ABCA2 CAND1 VPS13C RRBP1 CEMIP2 TECPR2 VPS50 DOLK HECTD4 SLC7A6 ADGRA2 UBE2O RAI14 CNOT1 | 4.99e-06 | 529 | 211 | 14 | 14621295 | |
| Pubmed | 5.91e-06 | 20 | 211 | 4 | 26694250 | ||
| Pubmed | 7.13e-06 | 76 | 211 | 6 | 27542412 | ||
| Pubmed | DCAF1 CAND1 RRBP1 DNAAF5 MDN1 AP2B1 CAVIN2 CIP2A UBR4 E2F4 DHX30 CCNE1 FANCI MACF1 RAI14 | 8.73e-06 | 634 | 211 | 15 | 34591612 | |
| Pubmed | AP2B1 UBAC1 PLEC HERC2 HERC1 MBOAT7 UBR4 VPS50 HECTD4 HUWE1 TRIM32 LRP2 MACF1 | 8.74e-06 | 481 | 211 | 13 | 28190767 | |
| Pubmed | 8.84e-06 | 22 | 211 | 4 | 31729367 | ||
| Pubmed | Cyclin M2 (CNNM2) knockout mice show mild hypomagnesaemia and developmental defects. | 1.21e-05 | 8 | 211 | 3 | 33859252 | |
| Pubmed | ABCA2 CAND1 ATRX RRBP1 UBE4A AP2B1 PLEC HERC2 UBR4 HECTD4 ZNFX1 HUWE1 DHX30 UBE2O TRIM32 SCG3 LRP2 MACF1 RAI14 PRKDC PALS2 GEN1 | 1.30e-05 | 1285 | 211 | 22 | 35914814 | |
| Pubmed | 1.51e-05 | 25 | 211 | 4 | 37451217 | ||
| Pubmed | Serotonin Regulates Adult β-Cell Mass by Stimulating Perinatal β-Cell Proliferation. | 2.07e-05 | 27 | 211 | 4 | 31806625 | |
| Pubmed | MON2 TGIF2 CYP2C9 CAND1 ATRX HMGCR SLC39A8 UBE4A NF1 ZBTB40 CAVIN2 TBCE UBR4 E2F4 DHX30 MST1 LINS1 DACH2 CDK13 SCG3 SEC63 CNOT1 | 2.12e-05 | 1327 | 211 | 22 | 32694731 | |
| Pubmed | Characterization of cDNA clones in size-fractionated cDNA libraries from human brain. | 2.33e-05 | 56 | 211 | 5 | 9455484 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 2.39e-05 | 313 | 211 | 10 | 38270169 | |
| Pubmed | 2.40e-05 | 28 | 211 | 4 | 25089626 | ||
| Pubmed | 2.40e-05 | 28 | 211 | 4 | 19737523 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 2.42e-05 | 94 | 211 | 6 | 21542922 | |
| Pubmed | MON2 CEMIP2 BLM NCAPG PTPRN VPS13A KCNMA1 MACROH2A2 HERC2 HERC1 AKAP5 CIP2A HUWE1 PTPN5 CNNM4 FANCI INTS4 RAI14 CNOT1 | 2.44e-05 | 1049 | 211 | 19 | 27880917 | |
| Pubmed | 2.56e-05 | 10 | 211 | 3 | 12970426 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | MON2 DCAF1 CNNM2 CAND1 UNC45A DNAAF5 AP2B1 CIP2A UBR4 HUWE1 PTPN5 CNNM4 SEPSECS UBE2O TRIM32 FANCI PRKDC SEC63 | 3.10e-05 | 974 | 211 | 18 | 28675297 |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 34260774 | ||
| Pubmed | Upregulation of proteasome activity in muscle RING finger 1-null mice following denervation. | 3.66e-05 | 2 | 211 | 2 | 22508689 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 27609031 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 29079751 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 20827784 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 38829391 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 26590085 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 20671242 | ||
| Pubmed | 5-HT1D and 5-HT2B receptors mediate contraction of smooth muscle in human small intestine. | 3.66e-05 | 2 | 211 | 2 | 9186750 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 17971512 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 10728827 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 16961763 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 22815045 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 19190184 | ||
| Pubmed | Identification of ubiquitin ligases required for skeletal muscle atrophy. | 3.66e-05 | 2 | 211 | 2 | 11679633 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 32017081 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 16826520 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 38203500 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 17008454 | ||
| Pubmed | Mammalian class theta GST and differential susceptibility to carcinogens: a review. | 3.66e-05 | 2 | 211 | 2 | 11018744 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 8617493 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 23844868 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 28474046 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 23761674 | ||
| Pubmed | The role of E3 ubiquitin-ligases MuRF-1 and MAFbx in loss of skeletal muscle mass. | 3.66e-05 | 2 | 211 | 2 | 26738803 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 21901639 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 22677788 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 19171937 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 38945286 | ||
| Pubmed | Adrenaline-induced colonic K+ secretion is mediated by KCa1.1 (BK) channels. | 3.66e-05 | 2 | 211 | 2 | 20351045 | |
| Pubmed | Mst1 regulates post-infarction cardiac injury through the JNK-Drp1-mitochondrial fission pathway. | 3.66e-05 | 2 | 211 | 2 | 29760744 | |
| Pubmed | Goblet cell hyperplasia is not epithelial-autonomous in the Cftr knockout intestine. | 3.66e-05 | 2 | 211 | 2 | 34878935 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 10878096 | ||
| Pubmed | Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids. | 3.66e-05 | 2 | 211 | 2 | 21807613 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 9060628 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 19577604 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 7688301 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 25876656 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 28930190 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 31206688 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 21700933 | ||
| Pubmed | Identification and characterization of GSTT3, a third murine Theta class glutathione transferase. | 3.66e-05 | 2 | 211 | 2 | 12038961 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 20522589 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 38149326 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 24706765 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 14578206 | ||
| Pubmed | Cone-rod dystrophy associated with amelogenesis imperfecta in a child with neurofibromatosis type 1. | 3.66e-05 | 2 | 211 | 2 | 21728811 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 21175599 | ||
| Pubmed | Effect of ramipril on kidney, lung and heart ACE2 in a diabetic mice model. | 3.66e-05 | 2 | 211 | 2 | 33811970 | |
| Interaction | C3orf18 interactions | HMGCR DNAAF5 UBE4A NCAPG NF1 MDN1 ARMH3 CIP2A INTS4 PRKDC SEC63 STAG2 | 1.24e-09 | 115 | 195 | 12 | int:C3orf18 |
| Interaction | C19orf38 interactions | 1.50e-07 | 86 | 195 | 9 | int:C19orf38 | |
| Interaction | SPPL2B interactions | CHRND CHRNE GPR180 UNC93B1 RFT1 GPAT4 PAQR7 MBOAT7 PIGS NTSR1 SLC35F2 HAS3 | 2.99e-06 | 233 | 195 | 12 | int:SPPL2B |
| Interaction | VIPR2 interactions | HMGCR DNAAF5 UNC93B1 RFT1 GPAT4 VIP CIP2A PIGS NTSR1 SLC7A6 SLC35F2 | 3.10e-06 | 194 | 195 | 11 | int:VIPR2 |
| Interaction | UNC93B1 interactions | MON2 CAND1 CFTR HMGCR DNAAF5 MDN1 UNC93B1 MBOAT7 CIP2A PIGS UBR4 CNNM4 FANCI PRKDC SEC63 STAG2 | 3.21e-06 | 417 | 195 | 16 | int:UNC93B1 |
| Interaction | OPALIN interactions | MON2 NF1 MDN1 UNC93B1 GPAT4 MBOAT7 CIP2A VPS50 DOLK FANCI PRKDC | 6.33e-06 | 209 | 195 | 11 | int:OPALIN |
| Interaction | POMK interactions | MON2 ATRX RRBP1 RFT1 GPAT4 MBOAT7 PIGS TMED7 SLC7A6 FANCI SLC35F2 PRKDC | 1.39e-05 | 271 | 195 | 12 | int:POMK |
| Interaction | PTP4A3 interactions | 1.96e-05 | 154 | 195 | 9 | int:PTP4A3 | |
| Interaction | P2RY6 interactions | MON2 CAND1 CFTR UNC45A UBE4A MDN1 CIP2A UBR4 THOC2 CNNM4 FANCI PRKDC SEC63 PCK2 | 2.45e-05 | 385 | 195 | 14 | int:P2RY6 |
| Interaction | VIPR1 interactions | TRPM6 CFTR HMGCR UNC93B1 GPAT4 VIP NTSR1 SLC7A6 INTS4 SLC35F2 | 3.23e-05 | 205 | 195 | 10 | int:VIPR1 |
| Interaction | FAF2 interactions | CYP2C9 CAND1 VPS13C CFTR HMGCR UNC45A NF1 VPS13A FBXO32 UBR4 HUWE1 PTPN5 ACE2 INTS4 PRKDC | 3.51e-05 | 451 | 195 | 15 | int:FAF2 |
| Interaction | GPR182 interactions | MON2 ABCA2 CAND1 DNAAF5 MDN1 UNC93B1 RFT1 GPAT4 CIP2A VPS50 NTSR1 SLC7A6 FANCI SLC35F2 PRKDC | 3.89e-05 | 455 | 195 | 15 | int:GPR182 |
| Interaction | MYL11 interactions | 4.47e-05 | 21 | 195 | 4 | int:MYL11 | |
| Interaction | FPR2 interactions | 6.04e-05 | 138 | 195 | 8 | int:FPR2 | |
| Interaction | P2RY8 interactions | 6.37e-05 | 179 | 195 | 9 | int:P2RY8 | |
| Interaction | VSIG1 interactions | 6.98e-05 | 72 | 195 | 6 | int:VSIG1 | |
| Interaction | CHRNA1 interactions | 8.89e-05 | 47 | 195 | 5 | int:CHRNA1 | |
| Interaction | KRT6C interactions | 9.47e-05 | 76 | 195 | 6 | int:KRT6C | |
| Interaction | SIGLECL1 interactions | 1.16e-04 | 113 | 195 | 7 | int:SIGLECL1 | |
| Interaction | HLA-B interactions | 1.17e-04 | 239 | 195 | 10 | int:HLA-B | |
| Interaction | ATOH1 interactions | 1.26e-04 | 80 | 195 | 6 | int:ATOH1 | |
| Interaction | VCP interactions | MON2 CYP2C9 ATRX CFTR NOL6 HMGCR RRBP1 ACOX3 BLM DNAAF5 UBE4A NCAPG NF1 MDN1 AP2B1 KCNMA1 UNC93B1 FBXO32 PLEC CACNA1C CIP2A UBR4 VPS50 TMED7 HUWE1 ACE2 FANCI PRKDC STAG2 | 1.27e-04 | 1435 | 195 | 29 | int:VCP |
| Interaction | LMBR1L interactions | CAND1 CFTR UNC45A GPR180 DNAAF5 NCAPG CEP78 PTPRN RFT1 MBOAT7 CIP2A PIGS UBR4 HUWE1 CNNM4 UBE2O TRIM32 FANCI PRKDC SEC63 STAG2 PCK2 | 1.30e-04 | 946 | 195 | 22 | int:LMBR1L |
| Interaction | C5AR1 interactions | 1.30e-04 | 154 | 195 | 8 | int:C5AR1 | |
| Interaction | CALM1 interactions | ATRX VPS13C CFTR LRRK2 OBSCN GLP2R CEP78 VPS13A KCNMA1 PLA2G6 HERC2 CACNA1C AKAP5 UBR4 HUWE1 CCNE1 ACE2 | 1.31e-04 | 626 | 195 | 17 | int:CALM1 |
| Interaction | BTNL9 interactions | 1.42e-04 | 156 | 195 | 8 | int:BTNL9 | |
| Interaction | TNFSF13B interactions | 1.60e-04 | 119 | 195 | 7 | int:TNFSF13B | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | PRAMEF25 PRAMEF9 SLC35E2B SLC35E2A ZBTB40 TRIM63 KLHDC7A PRAMEF11 PAQR7 HTR1D UBR4 PRAMEF15 PRAMEF4 MST1L PRAMEF27 | 6.94e-07 | 681 | 210 | 15 | chr1p36 |
| Cytoband | 1p36.21 | 1.08e-05 | 63 | 210 | 5 | 1p36.21 | |
| Cytoband | Xq21.1 | 4.65e-04 | 33 | 210 | 3 | Xq21.1 | |
| GeneFamily | PRAME family | 2.42e-08 | 24 | 141 | 6 | 686 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 2.41e-04 | 16 | 141 | 3 | 173 | |
| GeneFamily | Bardet-Biedl syndrome associated|BBSome | 5.57e-04 | 21 | 141 | 3 | 980 | |
| GeneFamily | Olfactory receptors, family 14 | 1.24e-03 | 7 | 141 | 2 | 163 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.64e-03 | 8 | 141 | 2 | 939 | |
| GeneFamily | CD molecules|Toll like receptors | 2.61e-03 | 10 | 141 | 2 | 948 | |
| GeneFamily | Transmembrane p24 trafficking proteins | 2.61e-03 | 10 | 141 | 2 | 1064 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 2.61e-03 | 10 | 141 | 2 | 830 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 3.17e-03 | 11 | 141 | 2 | 1168 | |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 4.45e-03 | 13 | 141 | 2 | 170 | |
| GeneFamily | ATP binding cassette subfamily A | 5.17e-03 | 14 | 141 | 2 | 805 | |
| GeneFamily | Butyrophilins|V-set domain containing|C2-set domain containing | 5.93e-03 | 15 | 141 | 2 | 458 | |
| GeneFamily | Chaperonins | 5.93e-03 | 15 | 141 | 2 | 587 | |
| GeneFamily | Olfactory receptors, family 52 | 6.58e-03 | 49 | 141 | 3 | 165 | |
| GeneFamily | Parkinson disease associated genes | 6.75e-03 | 16 | 141 | 2 | 672 | |
| Coexpression | GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_DN | DCAF1 DACH1 NDRG3 BTN3A3 HTR2B HGSNAT GPR183 SLC7A6 TRIM32 PCK2 | 3.27e-06 | 200 | 199 | 10 | M8040 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000 | CYP1B1 CAND1 CFTR DACH1 BLM NCAPG ABCD4 TRIM63 CAVIN2 CACNA1C NTSR1 GPR183 HUWE1 LEPR CCNE1 ACE2 DACH2 TLR2 RAI14 HAS3 SLC2A12 GEN1 NCKAP1L | 1.97e-06 | 855 | 187 | 23 | gudmap_developingKidney_e13.5_podocyte cells_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_1000 | MON2 ANKRD29 CYP1B1 CAND1 ATRX CFTR DACH1 BLM NCAPG NALCN TRIM63 CAVIN2 GPR183 HUWE1 LEPR ACE2 DACH2 TLR2 PDE5A HAS3 SLC2A12 NCKAP1L | 4.77e-06 | 836 | 187 | 22 | gudmap_developingKidney_e15.5_Podocyte cells_1000 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_500 | CAND1 CFTR DACH1 ABCD4 TRIM63 CAVIN2 NTSR1 GPR183 LEPR ACE2 DACH2 TLR2 RAI14 HAS3 GEN1 | 6.86e-06 | 431 | 187 | 15 | gudmap_developingKidney_e13.5_podocyte cells_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.26e-05 | 160 | 187 | 9 | gudmap_developingKidney_e15.5_Podocyte cells_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_top-relative-expression-ranked_1000 | ZBTB20 TMED6 CFTR LRRK2 DACH1 SLC39A8 SAMD9L PLA1A VPS13A ABCD4 HNF1B HUWE1 TRIM7 ACE2 SEPSECS LRP2 SLC35F2 HAS3 DEPDC7 | 4.27e-05 | 758 | 187 | 19 | gudmap_developingKidney_e15.5_Proximal Tubules_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_top-relative-expression-ranked_500 | TMED6 CFTR LRRK2 SLC39A8 SAMD9L PLA1A ABCD4 HNF1B HUWE1 TRIM7 ACE2 LRP2 HAS3 | 4.35e-05 | 389 | 187 | 13 | gudmap_developingKidney_e15.5_Proximal Tubules_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_500 | CAND1 DACH1 NALCN GLRX VPS13A KCNMA1 FBXO32 CAVIN2 PCED1A NTSR1 LEPR DACH2 PDE5A | 4.82e-05 | 393 | 187 | 13 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | CAND1 ZBTB20 ATRX DACH1 NALCN GLRX VPS13A KCNMA1 FBXO32 CAVIN2 PCED1A NIPAL4 NTSR1 HUWE1 ADGRA2 LEPR DACH2 PDE5A SLC2A12 | 5.46e-05 | 772 | 187 | 19 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_top-relative-expression-ranked_200 | 9.69e-05 | 162 | 187 | 8 | gudmap_developingKidney_e15.5_S-shaped body_200 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | MON2 ATP8B4 VPS13C HMGCR CEMIP2 UBE4A ZBTB40 KIF13B HUWE1 SLC7A6 MACF1 PRKDC | 9.82e-11 | 191 | 205 | 12 | 9454f642c3621370fa23640b631301346b300950 |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | MON2 ATP8B4 VPS13C HMGCR ZBTB40 HUWE1 SLC7A6 RASA4 MACF1 PRKDC SEC63 | 1.08e-09 | 185 | 205 | 11 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | MON2 ATP8B4 VPS13C ZBTB40 HUWE1 SLC7A6 RASA4 MACF1 PRKDC SEC63 | 1.65e-08 | 186 | 205 | 10 | 8571956890fc9894d766ba294a28e376b4aba428 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-08 | 195 | 205 | 10 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-07 | 172 | 205 | 9 | ef33b5e0515c6d29fb6d9a673011c1b68ef264f3 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-07 | 195 | 205 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-06 | 177 | 205 | 8 | d9c4a93b0e04a13bf39992dd1c1ec8df2c5f89fe | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-06 | 177 | 205 | 8 | ac8f774596068e66c0a9ea8a318be0ce5f5df834 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-06 | 178 | 205 | 8 | b0baf5667e3301898b3e45e974b8a8530af6a338 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-06 | 178 | 205 | 8 | 58857bb8c13e0e1c6d9f5c1258f00fff62063d68 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-06 | 178 | 205 | 8 | 8b7df6ab8709d9ab9dff97677cc4561aec2745bc | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.28e-06 | 184 | 205 | 8 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.68e-06 | 188 | 205 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-06 | 192 | 205 | 8 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | proximal-3-Hematologic-IGSF21+_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.51e-06 | 195 | 205 | 8 | 8592d0332bc82a91e173680cfd1afc5ee189b289 | |
| ToppCell | proximal-Hematologic-IGSF21+_Dendritic|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.51e-06 | 195 | 205 | 8 | c48ff83c48342875f06c6c9e7d5bc6084a992848 | |
| ToppCell | proximal-Hematologic-IGSF21+_Dendritic-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.51e-06 | 195 | 205 | 8 | ae9d61011e95f7840cbb154738c79745fd29943e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-06 | 195 | 205 | 8 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.78e-06 | 197 | 205 | 8 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.93e-06 | 198 | 205 | 8 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.93e-06 | 198 | 205 | 8 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.93e-06 | 198 | 205 | 8 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.07e-06 | 199 | 205 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp4_Mab21l1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.48e-06 | 96 | 205 | 6 | 78f19fee755061b4144b1beebb60f4e8bc4dbf0d | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-06 | 154 | 205 | 7 | 1e32969bee810adaf2d560f0824a16227df513d8 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.14e-06 | 159 | 205 | 7 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.14e-06 | 159 | 205 | 7 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.52e-06 | 160 | 205 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.52e-06 | 160 | 205 | 7 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.52e-06 | 160 | 205 | 7 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.52e-06 | 160 | 205 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-05 | 162 | 205 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 163 | 205 | 7 | 1e8730d75cccf7292010683ab4e81a69d8e3bfa9 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.21e-05 | 166 | 205 | 7 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.21e-05 | 166 | 205 | 7 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-05 | 172 | 205 | 7 | bfb87a281a9cf6ad45b310bf8104fc0ab382b549 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-05 | 172 | 205 | 7 | c6bc78fd63c9479a84ec0552b55c89750cad0fa5 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-05 | 175 | 205 | 7 | 74800a10f5ff25d5414fbccb0668f92ff077d1cc | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.83e-05 | 177 | 205 | 7 | 1d5a071157c755f3a27a5c3143015da04ee0b0dc | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-M/X_cells_(MLN/GHRL+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-05 | 177 | 205 | 7 | c80893e5cf5688ee9f5afc8f11b3890f296c9e1f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-05 | 178 | 205 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-05 | 179 | 205 | 7 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.19e-05 | 182 | 205 | 7 | 3cbeaf7904a76c32137a00abb20e302d3d3c8bb8 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 184 | 205 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 184 | 205 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 2.35e-05 | 184 | 205 | 7 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.35e-05 | 184 | 205 | 7 | 0a26bcc6610f756939e32a4d6dfeebcbf3a1db86 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.35e-05 | 184 | 205 | 7 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 184 | 205 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.43e-05 | 185 | 205 | 7 | 29d7ddcb9a2e45f76cd5611f7c52b6df689effd3 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.43e-05 | 185 | 205 | 7 | 780bdb63ef913a09930063286011c9108381d3a9 | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 185 | 205 | 7 | 6938ac3cab536cf8a474eba441ce6dcdfcc43b53 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.43e-05 | 185 | 205 | 7 | fec16a5e527fdef32d25957451b6e8ee9796cafd | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 185 | 205 | 7 | 0e7351cd6d6e6e8c29573042e168da50ee496cfc | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.52e-05 | 186 | 205 | 7 | de55471dd5c842026b409cfebf67fe32f079a011 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.61e-05 | 187 | 205 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-05 | 187 | 205 | 7 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-05 | 188 | 205 | 7 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.70e-05 | 188 | 205 | 7 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_ALM_Olfr111_Spon1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.72e-05 | 127 | 205 | 6 | cd69ba386796715e87674f8324d2acaad1d4d094 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.89e-05 | 190 | 205 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 191 | 205 | 7 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 3.19e-05 | 193 | 205 | 7 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | LAM-LAM-LAM+|LAM / Condition, Lineage and Cell class | 3.30e-05 | 194 | 205 | 7 | 4ba73a9145ed44896e359f6df9c1f32bbe24a189 | |
| ToppCell | LAM-LAM|LAM / Condition, Lineage and Cell class | 3.30e-05 | 194 | 205 | 7 | 4c6561a64711c72c4ef4a3e67c41d2e8d31fba57 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.30e-05 | 194 | 205 | 7 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.41e-05 | 195 | 205 | 7 | 4658fb197657d7692ee344ae76b11b0210c418ba | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.41e-05 | 195 | 205 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.53e-05 | 133 | 205 | 6 | 2ec3490cbf60152c3cece95eb566d749c9666517 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.64e-05 | 197 | 205 | 7 | 0542badae77d2f606c13cfaf361319495c354351 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Dendritic_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.64e-05 | 197 | 205 | 7 | e0fc098bfb5a8b7824ae339f3adda30f78360d0b | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.64e-05 | 197 | 205 | 7 | 76b61e60a757e58b465569538e632d6d9953e89a | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.64e-05 | 197 | 205 | 7 | a6a64581699cfcb9607b288976fa3b09648725b7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-05 | 197 | 205 | 7 | 6ca6e17b7cc5f7ea8d4b6ca1ff670969bee65a45 | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.64e-05 | 197 | 205 | 7 | f5d87824c0020c95d89e069fd9f70b49e5d5fcea | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 3.64e-05 | 197 | 205 | 7 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | ASK452-Epithelial-Transformed_epithelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.64e-05 | 197 | 205 | 7 | b22a79a5922c865a360e2afc5506a08a512fa76a | |
| ToppCell | medial-2-Epithelial-Alveolar_Epithelial_Type_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.75e-05 | 198 | 205 | 7 | 102a4cbb138adbfba11ed955420095daa098532f | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.75e-05 | 198 | 205 | 7 | 10a17d7c116dcd6cf847fe6f5d7196d887cad1f9 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.75e-05 | 198 | 205 | 7 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | medial-Epithelial-Alveolar_Epithelial_Type_2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.75e-05 | 198 | 205 | 7 | 53e5d76831d70b9a476f3ef3a81e13eda974d543 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / Treatment groups by lineage, cell group, cell type | 3.75e-05 | 198 | 205 | 7 | d087e738d69ca9853553fde46d4e7a8906439d32 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.75e-05 | 198 | 205 | 7 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.75e-05 | 198 | 205 | 7 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | medial-Epithelial-Alveolar_Epithelial_Type_2-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.75e-05 | 198 | 205 | 7 | 7caeed2d5dc78866023c8f38edcec9886baa9f2c | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.75e-05 | 198 | 205 | 7 | aa80315395cb5dffc25927c8a77cd2037aea8772 | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.88e-05 | 199 | 205 | 7 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.88e-05 | 199 | 205 | 7 | 744b63fba33b176ab7dde11646ccb313665505f7 | |
| ToppCell | distal-2-Epithelial-Alveolar_Epithelial_Type_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.88e-05 | 199 | 205 | 7 | 21b44031bc5182ee23ba5e206042b2e5e4ee0c3c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Crh|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.00e-05 | 136 | 205 | 6 | 44f03e4f55fb2c5f8b9397142c89f7194b009cc6 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.00e-05 | 200 | 205 | 7 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.00e-05 | 200 | 205 | 7 | cf1991853e10c562edae9a0d71a209f35b07db80 | |
| ToppCell | medial-Endothelial-Vein-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.00e-05 | 200 | 205 | 7 | 3f689029f5bc7db0af50a405f1e252aeec529077 | |
| ToppCell | distal-2-Endothelial-Vein|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.00e-05 | 200 | 205 | 7 | 2785225956d2422acab90e99b7debe3709cf3308 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.00e-05 | 200 | 205 | 7 | 7618ae284625c5c121bcc00eb9f07e5b1e3adf23 | |
| ToppCell | medial-2-Endothelial-Vein|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.00e-05 | 200 | 205 | 7 | 49da4e3ff10262a492c2cf566a7f2e35e418bfda | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.00e-05 | 200 | 205 | 7 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | medial-Endothelial-Vein|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.00e-05 | 200 | 205 | 7 | 1163e5f6dfb304c94bf8885629350454f4b6bee8 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.00e-05 | 200 | 205 | 7 | 27f498bcd706d0751091662996795b5270e46f14 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.00e-05 | 200 | 205 | 7 | 23b319bf7e5ae03e5baa777c951da9bfc97cca8c | |
| Drug | Ethotoin [86-35-1]; Up 200; 19.6uM; PC3; HT_HG-U133A | CNNM2 RRBP1 NF1 AP2B1 KCNMA1 PLA2G6 ARMH3 HNF1B E2F4 HUWE1 ADGRA2 CNNM4 | 2.19e-07 | 197 | 203 | 12 | 4545_UP |
| Disease | MYELODYSPLASTIC SYNDROME | 5.35e-06 | 67 | 194 | 6 | C3463824 | |
| Disease | Malignant neoplasm of breast | BOC ANKRD29 CYP1B1 CATSPERE OBSCN CHRND GPR180 NF1 KLHDC7A HERC2 PIGS UBR4 HELQ BTN3A2 LEPR CCNE1 MST1 CNNM4 MACF1 GEN1 | 2.98e-05 | 1074 | 194 | 20 | C0006142 |
| Disease | Parkinson's disease 23 (implicated_via_orthology) | 4.30e-05 | 2 | 194 | 2 | DOID:0060896 (implicated_via_orthology) | |
| Disease | choreaacanthocytosis (implicated_via_orthology) | 4.30e-05 | 2 | 194 | 2 | DOID:0050766 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease (biomarker_via_orthology) | 4.30e-05 | 2 | 194 | 2 | DOID:10595 (biomarker_via_orthology) | |
| Disease | quinate measurement | 1.20e-04 | 15 | 194 | 3 | EFO_0021167 | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 1.28e-04 | 3 | 194 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | Lethal multiple pterygium syndrome | 1.28e-04 | 3 | 194 | 2 | cv:C1854678 | |
| Disease | Infantile Neuroaxonal Dystrophy | 1.28e-04 | 3 | 194 | 2 | C0270724 | |
| Disease | Cohen syndrome (implicated_via_orthology) | 1.28e-04 | 3 | 194 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 1.28e-04 | 3 | 194 | 2 | 253290 | |
| Disease | Myasthenic Syndrome, Congenital, Fast-Channel | 1.28e-04 | 3 | 194 | 2 | C1837122 | |
| Disease | Pulmonary Hypertension | 1.38e-04 | 40 | 194 | 4 | C0020542 | |
| Disease | alkaline phosphatase measurement | CNNM2 CYP2C9 ZBTB20 RRBP1 CHRNE GPR180 NWD2 NF1 ZBTB40 PLA2G6 MBOAT7 CARMIL1 GSTT2B LEPR ABCA6 MACF1 RAI14 CNOT1 | 1.39e-04 | 1015 | 194 | 18 | EFO_0004533 |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 1.47e-04 | 16 | 194 | 3 | DOID:3635 (implicated_via_orthology) | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 1.78e-04 | 17 | 194 | 3 | C2936862 | |
| Disease | Bardet-Biedl syndrome | 2.12e-04 | 18 | 194 | 3 | cv:C0752166 | |
| Disease | MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL | 2.56e-04 | 4 | 194 | 2 | C4084823 | |
| Disease | Wilson disease (implicated_via_orthology) | 4.24e-04 | 5 | 194 | 2 | DOID:893 (implicated_via_orthology) | |
| Disease | Immunologic Deficiency Syndromes | 4.50e-04 | 23 | 194 | 3 | C0021051 | |
| Disease | Myasthenic Syndromes, Congenital | 5.12e-04 | 24 | 194 | 3 | C0751882 | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 6.34e-04 | 6 | 194 | 2 | C1854678 | |
| Disease | glucagon measurement, glucose tolerance test | 6.34e-04 | 6 | 194 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | Acute monocytic leukemia | 6.51e-04 | 26 | 194 | 3 | C0023465 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 8.12e-04 | 28 | 194 | 3 | DOID:1094 (implicated_via_orthology) | |
| Disease | Ciliopathies | 8.17e-04 | 110 | 194 | 5 | C4277690 | |
| Disease | Obesity, Morbid | 8.84e-04 | 7 | 194 | 2 | C0028756 | |
| Disease | Miller Dieker syndrome | 9.01e-04 | 29 | 194 | 3 | C0265219 | |
| Disease | Hematopoetic Myelodysplasia | 9.01e-04 | 29 | 194 | 3 | C2713368 | |
| Disease | primary pulmonary hypertension (is_marker_for) | 1.17e-03 | 8 | 194 | 2 | DOID:14557 (is_marker_for) | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 1.17e-03 | 8 | 194 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | holoprosencephaly (is_implicated_in) | 1.17e-03 | 8 | 194 | 2 | DOID:4621 (is_implicated_in) | |
| Disease | generalized anxiety disorder (implicated_via_orthology) | 1.17e-03 | 8 | 194 | 2 | DOID:14320 (implicated_via_orthology) | |
| Disease | Rhinitis | 1.17e-03 | 8 | 194 | 2 | C0035455 | |
| Disease | nucleotide measurement | 1.38e-03 | 73 | 194 | 4 | EFO_0010513 | |
| Disease | Todd Paralysis | 1.50e-03 | 9 | 194 | 2 | C0234544 | |
| Disease | Paralysed | 1.50e-03 | 9 | 194 | 2 | C0522224 | |
| Disease | pulmonary sarcoidosis (is_implicated_in) | 1.50e-03 | 9 | 194 | 2 | DOID:13406 (is_implicated_in) | |
| Disease | platelet component distribution width | KREMEN1 LRRK2 SLC39A8 CHRNE AP2B1 PLA2G6 PLEC HERC1 CACNA1C CARMIL1 UBE2O MACF1 DEPDC7 | 1.55e-03 | 755 | 194 | 13 | EFO_0007984 |
| Disease | platelet crit | ZBTB20 ATRX LRRK2 DACH1 HMGCR RRBP1 CHRNE NF1 OR14A2 PLEC CACNA1C CARMIL1 LEPR CDK13 PDE5A | 1.65e-03 | 952 | 194 | 15 | EFO_0007985 |
| Disease | Primary ciliary dyskinesia | 1.70e-03 | 36 | 194 | 3 | cv:C0008780 | |
| Disease | Growth Disorders | 1.70e-03 | 36 | 194 | 3 | C0018273 | |
| Disease | Depression, Bipolar | 1.85e-03 | 79 | 194 | 4 | C0005587 | |
| Disease | Cardiomegaly | 2.12e-03 | 82 | 194 | 4 | C0018800 | |
| Disease | Cardiac Hypertrophy | 2.12e-03 | 82 | 194 | 4 | C1383860 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.15e-03 | 200 | 194 | 6 | EFO_0004611, EFO_0020945 | |
| Disease | Ashkenazi Jewish disorders | 2.27e-03 | 11 | 194 | 2 | cv:CN118946 | |
| Disease | Profound Mental Retardation | 2.30e-03 | 139 | 194 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.30e-03 | 139 | 194 | 5 | C0025363 | |
| Disease | Mental deficiency | 2.30e-03 | 139 | 194 | 5 | C0917816 | |
| Disease | Obesity | 2.43e-03 | 205 | 194 | 6 | C0028754 | |
| Disease | Diaphragmatic Hernia | 2.48e-03 | 41 | 194 | 3 | C0019284 | |
| Disease | survival time, lung adenocarcinoma | 2.72e-03 | 12 | 194 | 2 | EFO_0000571, EFO_0000714 | |
| Disease | Intellectual Disability | 2.95e-03 | 447 | 194 | 9 | C3714756 | |
| Disease | lipid measurement, lipoprotein measurement | 2.98e-03 | 90 | 194 | 4 | EFO_0004529, EFO_0004732 | |
| Disease | 3-formylindole measurement | 3.20e-03 | 13 | 194 | 2 | EFO_0801025 | |
| Disease | Neurodegeneration with brain iron accumulation | 3.20e-03 | 13 | 194 | 2 | cv:C2931845 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 3.20e-03 | 150 | 194 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 3.24e-03 | 45 | 194 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 3.24e-03 | 45 | 194 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.25e-03 | 291 | 194 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | Primary Ciliary Dyskinesia | 3.67e-03 | 47 | 194 | 3 | C4551720 | |
| Disease | Metabolic Bone Disorder | 3.72e-03 | 14 | 194 | 2 | C0005944 | |
| Disease | Bardet-Biedl syndrome (is_implicated_in) | 3.72e-03 | 14 | 194 | 2 | DOID:1935 (is_implicated_in) | |
| Disease | Fanconi anemia | 3.72e-03 | 14 | 194 | 2 | cv:C0015625 | |
| Disease | Autosomal recessive limb-girdle muscular dystrophy | 3.72e-03 | 14 | 194 | 2 | cv:C2931907 | |
| Disease | schizophrenia, anorexia nervosa | 3.89e-03 | 48 | 194 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | apolipoprotein A 1 measurement | TMED6 RRBP1 MIDEAS SLC39A8 GPR180 BTN3A3 OR13D1 PLA2G6 HERC1 LEPR ABCA6 MACF1 CNOT1 | 4.19e-03 | 848 | 194 | 13 | EFO_0004614 |
| Disease | congenital disorder of glycosylation type I (implicated_via_orthology) | 4.27e-03 | 15 | 194 | 2 | DOID:0050570 (implicated_via_orthology) | |
| Disease | Muscular Atrophy | 4.27e-03 | 15 | 194 | 2 | C0026846 | |
| Disease | Osteopenia | 4.27e-03 | 15 | 194 | 2 | C0029453 | |
| Disease | Neurogenic Muscular Atrophy | 4.27e-03 | 15 | 194 | 2 | C0270948 | |
| Disease | Psychotic Disorders | 4.50e-03 | 101 | 194 | 4 | C0033975 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 4.50e-03 | 101 | 194 | 4 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 4.86e-03 | 16 | 194 | 2 | C0751885 | |
| Disease | liver fat measurement, liver disease biomarker | 4.86e-03 | 16 | 194 | 2 | EFO_0006845, EFO_0010821 | |
| Disease | platelet measurement | 4.99e-03 | 315 | 194 | 7 | EFO_0005036 | |
| Disease | bipolar disorder | SLC39A8 STARD9 PLEC CACNA1C CARMIL1 HUWE1 BTN3A2 CNNM4 PDE5A PALS2 | 5.07e-03 | 577 | 194 | 10 | MONDO_0004985 |
| Disease | immature platelet count | 5.34e-03 | 106 | 194 | 4 | EFO_0803544 | |
| Disease | pulmonary hypertension (implicated_via_orthology) | 5.43e-03 | 54 | 194 | 3 | DOID:6432 (implicated_via_orthology) | |
| Disease | Inborn Errors of Metabolism | 5.48e-03 | 17 | 194 | 2 | C0025521 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 5.48e-03 | 17 | 194 | 2 | C0751883 | |
| Disease | renal fibrosis (implicated_via_orthology) | 5.48e-03 | 17 | 194 | 2 | DOID:0050855 (implicated_via_orthology) | |
| Disease | Antibody Deficiency Syndrome | 5.48e-03 | 17 | 194 | 2 | C0003257 | |
| Disease | Moyamoya Disease | 5.48e-03 | 17 | 194 | 2 | C0026654 | |
| Disease | PR interval | 5.70e-03 | 495 | 194 | 9 | EFO_0004462 | |
| Disease | Ischemic stroke, fibrinogen measurement | 5.71e-03 | 55 | 194 | 3 | EFO_0004623, HP_0002140 | |
| Disease | leukemia | 5.71e-03 | 55 | 194 | 3 | C0023418 | |
| Disease | Schizophrenia | CNNM2 KREMEN1 PLA2G6 IL19 CACNA1C VIP NTSR1 PTPN5 GSTT2 TLR2 TPH2 ERVK-8 LRP2 | 5.84e-03 | 883 | 194 | 13 | C0036341 |
| Disease | Leukemia, Myelocytic, Acute | 5.84e-03 | 173 | 194 | 5 | C0023467 | |
| Disease | smoking cessation | 5.90e-03 | 325 | 194 | 7 | EFO_0004319 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 6.01e-03 | 56 | 194 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | Cholestasis | 6.08e-03 | 110 | 194 | 4 | C0008370 | |
| Disease | nevus count | 6.14e-03 | 18 | 194 | 2 | EFO_0004632 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 6.14e-03 | 18 | 194 | 2 | HP_0002373 | |
| Disease | Bone marrow hypocellularity | 6.14e-03 | 18 | 194 | 2 | C1855710 | |
| Disease | Hypertrophic Cardiomyopathy | 6.31e-03 | 57 | 194 | 3 | C0007194 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LALTLSNLISLKEVE | 56 | Q07001 | |
| GNTLVILAVSLEKKL | 71 | P41595 | |
| KTIGSTTIINLILIL | 631 | O71037 | |
| KTIGSTTIINLILIL | 631 | Q902F8 | |
| ESTQVQLTLLTAIVK | 476 | P63010 | |
| VLDKISIGQLVSLLS | 171 | P13569 | |
| IIRNSLLGLEKTASI | 221 | O00478 | |
| LVTTTELKNILSLSV | 371 | Q5SY80 | |
| SGRVSIVSLAILNLK | 306 | O15254 | |
| IVSLAILNLKLAVAI | 311 | O15254 | |
| TVTLLLSNNKITGLR | 86 | Q96PE1 | |
| VNVSLKLTLTNLISL | 51 | P07510 | |
| LLLVTVSSNLAIAIK | 11 | Q8TD06 | |
| LLQSEATKLVTIGLI | 106 | P47775 | |
| LVLGQKLSLTQSDIS | 191 | Q9P0M6 | |
| QTKVLLTLLLVFGIA | 851 | Q8N139 | |
| ENVVKTLLQLIGISS | 181 | P24864 | |
| VLSGNIKTVALLLEA | 251 | Q8N6D5 | |
| LKLLLCLVTVTDNIS | 161 | Q5T2E6 | |
| VIETVTSLSLANIKI | 656 | Q8TF62 | |
| LSISSVLKNLELNGL | 116 | Q5JTW2 | |
| SLQVLSKILAIEKSG | 1221 | Q96M86 | |
| TEIALEATQLLLKLL | 336 | Q96QD5 | |
| DLSLKISEGQSLLIT | 406 | O14678 | |
| KIVLATNIAETSITI | 726 | Q7L2E3 | |
| LLKTEGINLVTAVLT | 491 | Q6ZW61 | |
| QLLTSVLQCLTKILT | 686 | Q8TAM1 | |
| SSIETLLTNIQGLLK | 616 | Q9UI36 | |
| ETLLTNIQGLLKVAL | 456 | Q96NX9 | |
| ELAILLNLLQSKTSV | 1091 | Q14004 | |
| LLLLGSALVSVLTKE | 116 | O75185 | |
| ISLKVTLTNLISLNE | 51 | Q04844 | |
| LLLLVNTVVKDLQST | 131 | Q9UPM8 | |
| KLISLQATEATIVTL | 811 | Q04656 | |
| QSAVLICKALSIELL | 1201 | Q9ULI1 | |
| TSRTLLLLAKAVQNV | 496 | O43374 | |
| QDLLSLLQAKVASLT | 346 | Q9P0K7 | |
| TSRTLLLLAKAVQNV | 496 | C9J798 | |
| SLLKLALLAGLTITV | 331 | Q96AA3 | |
| VLAQLLDTLLAIGTK | 126 | Q96HW7 | |
| ATNLVSSLLTLLKQL | 116 | P54829 | |
| ISGALLQIKTLLALS | 61 | Q8TD20 | |
| FTIIALILLDSQLKT | 41 | A6NIJ9 | |
| EALLLVTVLTSLSKL | 981 | Q9NVI1 | |
| LIGNFTILLVIKTDS | 41 | Q8NGJ4 | |
| SKLSGLTTNVVDIIL | 176 | Q9UGV2 | |
| SNNGIKVLLSLLSIK | 731 | Q9Y4B6 | |
| LVKSELEAQTGLQIL | 536 | Q16849 | |
| GNLTIILVSRLDTKL | 41 | P58173 | |
| SILTAFLLSQLVQRK | 326 | Q86WK9 | |
| NVLKLLGKLSTQIST | 1341 | Q9NU22 | |
| SLLLGEKTIILSRQT | 166 | Q7Z353 | |
| VLQAVNSGLLKTLSV | 341 | Q8NG48 | |
| ISFVLNQLIKRSLTL | 201 | Q9UPQ8 | |
| NSIKLVNLLSIFIST | 296 | Q12791 | |
| VISVLNTIIANKLTV | 251 | P30989 | |
| SQLVLLKLERSVTLN | 571 | Q2TV78 | |
| ELVVSIVLLLSKNAG | 1136 | O95714 | |
| EQVITLSLALLLAVK | 321 | P04035 | |
| NVTILSTLETLQIIK | 56 | Q9UHD0 | |
| LTTLLLQHNQIKVLT | 131 | Q8N6Y2 | |
| SIKGQVILTLNSTLV | 36 | A6NEK1 | |
| LKVASTRLLQILAIT | 1811 | Q15751 | |
| TSEALLVTQQLVKVI | 536 | Q86VP6 | |
| TATLTLLEQQGLIRK | 71 | Q16822 | |
| LLILKTVLGLTREAQ | 221 | Q8TCB6 | |
| LITLVGNTAIILASL | 36 | Q9Y3N9 | |
| IALIGNSLLLIIIKS | 41 | A6NMU1 | |
| TTLAADKLIILFNIV | 261 | Q8NGB4 | |
| TTLKIIKQAILATDL | 711 | O76074 | |
| VLLLQKDSLLTAAQL | 51 | Q9H1Q7 | |
| LQLLSTILSSAQGLK | 311 | Q9H6R4 | |
| LKEFLVVASVSLLQL | 1056 | P55160 | |
| TLENLLSHTIILKNL | 396 | P0DUQ1 | |
| LQTLEIELQSLLATK | 311 | Q7Z3Y8 | |
| LQTLEIELQSLLATK | 306 | Q7Z3Z0 | |
| ALLKQTTGEEVLLIQ | 1646 | O94854 | |
| LSVIGLKTLDLLLTS | 131 | Q5S007 | |
| TNAVQLLLTLKLVSL | 101 | Q96N66 | |
| LLLTLKLVSLASEVQ | 106 | Q96N66 | |
| SSVKAEITINIGLLK | 541 | P48357 | |
| LATLLILTVTAIVAK | 396 | Q96MU8 | |
| VKLLQLIAKSQLTSL | 126 | Q8TCJ0 | |
| LLLLVASQNKIIADS | 1436 | P98164 | |
| LKVLTTALLLQAGSA | 206 | Q86V85 | |
| ELKLLQTVLVLLTTN | 121 | Q7Z3U7 | |
| ILLVFLTSIASNVVK | 31 | Q8NH04 | |
| LKVQELKVSILALAT | 481 | Q9Y4D8 | |
| LKVSILALATQILTG | 486 | Q9Y4D8 | |
| IRLVQILQKGLSITT | 191 | Q96KD3 | |
| SIILSILEQAAKKTL | 211 | P0CG30 | |
| SGILNVLIKLLEVVQ | 1551 | Q7Z6Z7 | |
| KTIGSTTIINLILIL | 1391 | P63135 | |
| IQSSGRVLQIAKTLL | 1876 | Q96RW7 | |
| SLVILLNKSTVLECI | 3721 | Q96RW7 | |
| SLATLTLLGKLVDAI | 151 | Q5TIA1 | |
| LATVLGNLLIILSVS | 36 | O43749 | |
| EIIKNQLRISLIALT | 246 | Q8NB91 | |
| ISATLKNFQLLTILV | 7511 | Q5VST9 | |
| QELLKNISGSVTLKI | 191 | Q9NZW5 | |
| KVLVFSQSLISLDLI | 2036 | P46100 | |
| TVLGSSQIILVKFIN | 4936 | Q4G0P3 | |
| VLLVSIKQVTGSLLE | 56 | O95838 | |
| LSLKSLVNKGILVQT | 86 | P22492 | |
| EAQTIIVTKGQSLIL | 236 | Q9BWV1 | |
| LRSLIVDQVQKLTSL | 716 | P54132 | |
| IQSSAINVVKILRVL | 1006 | Q13936 | |
| SLGLLTTKFVSLLQE | 21 | Q16254 | |
| KTIGSTTIINLILIL | 631 | P61570 | |
| KTIGSTTIINLILIL | 631 | Q69384 | |
| IVNLLGISLTVLFTL | 11 | Q86UL3 | |
| LVSLQQSGELLTRLK | 86 | P35754 | |
| SIILSILEQAAKKTL | 211 | P0CG29 | |
| ILQAVTLQTSLLKLE | 646 | Q9NSG2 | |
| NLILDLIKTGRSVVL | 2226 | Q9BZC7 | |
| LLIETASSLVKNAIQ | 391 | P24588 | |
| ALKISLAVVLSVITL | 36 | P28221 | |
| INFLLKQALTIVGTL | 436 | Q9BYF1 | |
| IVLLSTRGEIKQLNI | 1286 | Q9UHN6 | |
| IIRNSLLGLEKTASI | 221 | P78410 | |
| LLTLAQKAVELASLQ | 466 | Q6PJG2 | |
| LAIQQIKAVSKSLIS | 551 | Q17RS7 | |
| QLTGKVVLSAAALLL | 16 | Q5VTJ3 | |
| ILGLISVALTKVSEN | 541 | Q68CP4 | |
| VLLEQSGIDILNKIS | 821 | Q5VZK9 | |
| LSIQQTTLLLLLSVL | 16 | Q16678 | |
| LFLLTVQLVGIIKAT | 411 | O00219 | |
| KTIGSTTIINLILIL | 631 | Q902F9 | |
| NILQIGIKDISKSLT | 41 | P11712 | |
| SLQLLDVLLTIVALA | 516 | Q86Y56 | |
| TLFLSLIGLKIATNL | 756 | Q8TDG4 | |
| GSQLVLLKLERSVTL | 566 | P26927 | |
| LELIAKSQLTSLSGI | 126 | Q969P5 | |
| SQVNAVTVLTLLDKL | 51 | O95810 | |
| IVKLVSVLSTIINST | 1116 | Q8TE73 | |
| TLLGNLLIIISVKTS | 36 | Q8NGL9 | |
| LLIIISVKTSQALKN | 41 | Q8NGL9 | |
| LGSLNILLLTLTAQE | 171 | P03905 | |
| LIISTILKIASAEGQ | 221 | Q5JRS4 | |
| LLKLVCSDITINVLI | 216 | Q8NGV5 | |
| LLVNLLSSQKTIIFS | 81 | Q8NGT1 | |
| LLIITLITLDVKLQT | 41 | Q96R54 | |
| IAKALSIQDLVIALT | 261 | A6ND48 | |
| LLGNATILLVIKVEQ | 41 | Q8NH60 | |
| TLTSLAQLLGKISNI | 441 | Q96S52 | |
| LLSSGVTKEVLVQAL | 16 | P35680 | |
| LVSIISKTVVLGLAL | 291 | Q75VX8 | |
| INKSLTTLGLVISAL | 276 | Q9NQT8 | |
| KALQTVTSFLILLAI | 226 | P59543 | |
| TSLTQLTDNLTVLKI | 71 | Q13049 | |
| IQISASINKKLGLLS | 1146 | O60522 | |
| TLILNGNKLETLSLV | 376 | Q9BXR5 | |
| LLGLAITTLVQAVDK | 11 | Q9H3W5 | |
| TLNIELVNSTILKLK | 611 | Q8IVG5 | |
| SGVNKKALNTIILII | 236 | P32249 | |
| TLENLLSHTIILKNL | 396 | A6NGN4 | |
| TVVLGLVSLKNVAVS | 156 | P0CK97 | |
| TLENLLSHTIILKNL | 396 | A3QJZ7 | |
| LIIIQLLIAIEKASG | 491 | O60733 | |
| KTNIADLVTALIVLL | 256 | P40879 | |
| NKSLVTLGIVISTLA | 276 | Q9P2P6 | |
| LVIKVTSATSVNLGI | 281 | Q8IXU6 | |
| LSTKVRNSVLLLIQT | 366 | Q7Z745 | |
| KLSLSGQTNLSVLQI | 51 | Q9GZN2 | |
| KTLDALVIATGLVTL | 61 | O60543 | |
| SLILSIIGLLSQLAV | 71 | Q8TCG1 | |
| IGQQLILIIKSLDTS | 401 | Q9BPX3 | |
| SIFLGVKLLQVSTIA | 51 | Q6UXN8 | |
| LGNVLVNTTLTILLD | 321 | Q9H8M5 | |
| LLLGNVLVNTSLTIL | 246 | Q6P4Q7 | |
| TVTKINLLNKVLGIV | 1956 | A5YKK6 | |
| TGLLTLRQIVLSKVD | 571 | Q9BYT8 | |
| LLTAKQLIKSIVEAS | 276 | Q969Q1 | |
| SAVKNVIKLSLEISL | 131 | Q53H76 | |
| TLENLLSHTIILKNL | 396 | O60810 | |
| ILTNTTLNVIRLVGK | 606 | Q96JG6 | |
| LGVEITQLSKLSSQI | 256 | Q9C029 | |
| KLAVLLVTLVAAAVS | 496 | Q9H1C4 | |
| LKLSTNEDIITLQIL | 1041 | Q96RL7 | |
| SITSDLILENIKSLI | 186 | Q8NI27 | |
| LQDLSALTVDTLKVL | 1211 | Q9BX84 | |
| VVNSIQVLTSKAAIL | 156 | Q9P2E9 | |
| LITQFVSSRLQAIKL | 506 | P60508 | |
| LLIIASIGQLKTLNK | 356 | Q15813 | |
| VAVQAIKLLTLVLQS | 386 | Q8N3U4 | |
| IKLLTLVLQSSEEVL | 391 | Q8N3U4 | |
| VSDITISLIQQKLSV | 371 | O94759 | |
| TLENLLSHTIILKNL | 396 | P0DUQ2 | |
| ILLVVSIGQVFLLKS | 196 | Q9Y3B3 | |
| TSKSSLLQVLISIQG | 1056 | Q9C0C9 | |
| TAQSLVIILSGILQL | 206 | Q8WW62 | |
| FSLVISGLTTILKNV | 51 | P21359 | |
| TLENLLSHTIILKNL | 396 | O60813 | |
| NITVGSLVTVLVKLT | 461 | Q9UGP8 | |
| VNLLLKSIGATLTDV | 3361 | Q709C8 | |
| TVVLGLVSLKNVAVS | 156 | P0CK96 | |
| SQKVLLVSTLQRSLL | 181 | O15040 | |
| SLVVITKGQTILLDQ | 2196 | Q86WI1 | |
| TTGIINKLVTVLAQI | 141 | A2RU48 | |
| NKLVTVLAQIGASLL | 146 | A2RU48 | |
| LTLGKLEQVRSLSAI | 1206 | Q15149 | |
| ELIQLLKFQTTIVTL | 121 | Q8IWU9 | |
| ILSLILALSLSTQVN | 266 | Q0D2K0 | |
| LALLAKILQIDSSVS | 1646 | P78527 | |
| VITLATSLGLKELLS | 161 | Q9P2E3 | |
| LQILTAASILQIKTV | 171 | Q9HC78 | |
| EKILQLLQSTGTVIL | 576 | O60290 | |
| LKKEISLLNGVSLVV | 41 | Q92536 | |
| KVFVILQLSLALTGV | 406 | Q9BY10 | |
| VTIINLASLLGLILT | 136 | Q9C0K1 | |
| SSLLNKITNSLVLDI | 111 | Q9HD40 | |
| KITNSLVLDIIKLAG | 116 | Q9HD40 | |
| LVSLIEVAQKLLALN | 156 | Q9BSL1 | |
| QKTLLGVILSISCLL | 326 | Q14139 | |
| ITVLQLSALLKQADS | 1921 | Q5T4S7 | |
| SDLSLIIAQIVQKLK | 6 | Q8N5T2 | |
| GETLLTLKNLTNIDI | 406 | O60603 | |
| KAQLLVLLTLLSVLF | 6 | P01282 | |
| IVSKLLNLGLITESQ | 171 | Q8WXD2 | |
| LKVLISNLLDLLTEV | 291 | Q9H3U1 | |
| TLTAEGLVKLLQAVK | 416 | Q9NUA8 | |
| IALLVLAQSVLLSVK | 1216 | Q8IZF0 |